Viacreme is a topical formulation of menthol and L-arginine in an aqueous base. It is promoted to enhance sexual responsiveness in women by sensitizing the genital area. Cancer patients may experience symptoms of sexual dysfunction that include painful intercourse, loss of libido, and difficulty in maintaining arousal. These problems may be caused by factors such as stress, hormonal changes, and treatment involving surgery, radiation, chemotherapy, or hormone therapy. Application of Viacreme is believed to cause genital warming and increase clitoral sensitivity, although these results may be due to placebo effects.
No clinical trials have been conducted to study the efficacy of Viacreme. Use of Viacreme may cause a sensation of strong genital burning.
This product has not been studied in cancer patients.
- Female sexual dysfunction
- Menthol (0.25 - 0.5%)
Mechanism of Action
The menthol in Viacreme is thought to facilitate absorption of L-arginine and cause increase in vaginal lubrication. The L-arginine is converted to nitric oxide by nitric oxide synthase that may result in vasodilation of the genital tissues.
Following application, the active components of Viacreme may be absorbed topically.
Sexual dysfunction could be a result of other complex underlying physical, biological, or psychological disorders. Patients should consult and be monitored by a physician when using this product.
- Hypersensitivity to any of the ingredients
- Vulvar irritation, atrophy, or infection
Application of Viacreme may cause a sensation of strong genital burning.
Literature Summary and Critique
No human studies have been conducted so far to test the efficacy of Viacreme.